Tristel PLC (AIM:TSTL) said it will pay a special dividend of 3 pence per share after revenue rose in the second half.
The manufacturer of infection prevention products said revenue and adjusted pretax profit for the year from the continuing operations will be in line with consensus forecasts of £28.4mln and £4.5mln respectively.
It attributed the rise in revenue in the six months to end-June to an increase in patient procedures carried out by hospitals, as they gradually returned to normal levels of service, and on higher sales of surface disinfectants.
“During the year, 15.7mln disinfection events took place with a Tristel medical device disinfectant, which is 31% higher than in the year ended 30 June 2019, before the pandemic struck,” chief executive Paul Swinney said, adding that the outlook for the company was positive.
Tristel said it continues to be cash generative and reported a cash balance of £9mln at the end of June.
It plans to pay the special dividend on 10 August and said it will declare a final dividend for the year of 3.93 pence, the same as the previous year, at the time of its full-year results in October.
In the second half, Tristel focussed on its proprietary chlorine dioxide technology in the hospital market, having wound down its non-core activities in the first half.